PP can be included in the cavities of cyclodextrin (CD). The crystalline inclusion complex between β-CD and lowmolecular weight polypropylene (PP) was obtained and investigated. α-CD and γ-CD did not form crystalli...PP can be included in the cavities of cyclodextrin (CD). The crystalline inclusion complex between β-CD and lowmolecular weight polypropylene (PP) was obtained and investigated. α-CD and γ-CD did not form crystalline inclusioncomplexes with PP. The FTIR spectra, TGA, X-ray diffraction spectra were studied, ~1H-NMR spectra and ^(13)C CP/MAS NMR spectra were used to characterize the crystalline inclusion complexes.展开更多
The solid forms of drugs play a central role in controlling their physicochemical properties and consequently the bioavailability. Multiple types of drug solid forms have been developed to achieve the desirable pharma...The solid forms of drugs play a central role in controlling their physicochemical properties and consequently the bioavailability. Multiple types of drug solid forms have been developed to achieve the desirable pharmaceutical profiles, but new solid forms will provide more options for the solid-state property optimization and hence are highly desirable. This review focuses on a new pharmaceutical solid form, drug-polymer inclusion complexes （ICs）, and summarizes their structural features, structure- property relationships, as well as potential pharmaceutical applications展开更多
基金This work was financially supported by the National Natural Science Foundation of China (Grant No. 29974017) and the fund of the Analytical Center and the Key Laboratory of Education Ministry for Optical and Magnetic Resonance Spectroscopy also sponsored
文摘PP can be included in the cavities of cyclodextrin (CD). The crystalline inclusion complex between β-CD and lowmolecular weight polypropylene (PP) was obtained and investigated. α-CD and γ-CD did not form crystalline inclusioncomplexes with PP. The FTIR spectra, TGA, X-ray diffraction spectra were studied, ~1H-NMR spectra and ^(13)C CP/MAS NMR spectra were used to characterize the crystalline inclusion complexes.
基金supported by the National Natural Science Foundation of China (No. 21434008)
文摘The solid forms of drugs play a central role in controlling their physicochemical properties and consequently the bioavailability. Multiple types of drug solid forms have been developed to achieve the desirable pharmaceutical profiles, but new solid forms will provide more options for the solid-state property optimization and hence are highly desirable. This review focuses on a new pharmaceutical solid form, drug-polymer inclusion complexes （ICs）, and summarizes their structural features, structure- property relationships, as well as potential pharmaceutical applications
